These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 15161358

  • 21. A-bomb survivors: factors that may lead to a re-assessment of the radiation hazard.
    Stewart AM, Kneale GW.
    Int J Epidemiol; 2000 Aug; 29(4):708-14. PubMed ID: 10922349
    [Abstract] [Full Text] [Related]

  • 22. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure.
    Imaizumi M, Usa T, Tominaga T, Neriishi K, Akahoshi M, Nakashima E, Ashizawa K, Hida A, Soda M, Fujiwara S, Yamada M, Ejima E, Yokoyama N, Okubo M, Sugino K, Suzuki G, Maeda R, Nagataki S, Eguchi K.
    JAMA; 2006 Mar 01; 295(9):1011-22. PubMed ID: 16507802
    [Abstract] [Full Text] [Related]

  • 23. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP.
    J Radiol Prot; 2009 Jun 01; 29(2A):A43-59. PubMed ID: 19454804
    [Abstract] [Full Text] [Related]

  • 24. Impact on the Japanese atomic bomb survivors of radiation received from the bombs.
    Cullings HM.
    Health Phys; 2014 Feb 01; 106(2):281-93. PubMed ID: 24378504
    [Abstract] [Full Text] [Related]

  • 25. High Initial-dose Dependency of Cerebrovascular Disease Mortality among Female Survivors of the Hiroshima Atomic Bomb Exposed in Teens: A Cohort Study, 1970-2010.
    Matsuba J, Otani K, Satoh K, Kawakami H, Ohtaki M.
    Hiroshima J Med Sci; 2016 Sep 01; 65(2):35-43. PubMed ID: 29989683
    [Abstract] [Full Text] [Related]

  • 26. Dose response and temporal patterns of radiation-associated solid cancer risks.
    Preston DL, Pierce DA, Shimizu Y, Ron E, Mabuchi K.
    Health Phys; 2003 Jul 01; 85(1):43-6. PubMed ID: 12852470
    [Abstract] [Full Text] [Related]

  • 27. Radiation dose associated with renal failure mortality: a potential pathway to partially explain increased cardiovascular disease mortality observed after whole-body irradiation.
    Adams MJ, Grant EJ, Kodama K, Shimizu Y, Kasagi F, Suyama A, Sakata R, Akahoshi M.
    Radiat Res; 2012 Feb 01; 177(2):220-8. PubMed ID: 22149958
    [Abstract] [Full Text] [Related]

  • 28. Effect of radiation dose on the height of atomic bomb survivors: a longitudinal study.
    Nakashima E, Fujiwara S, Funamoto S.
    Radiat Res; 2002 Sep 01; 158(3):346-51. PubMed ID: 12175312
    [Abstract] [Full Text] [Related]

  • 29. Radiation dose and cataract surgery incidence in atomic bomb survivors, 1986-2005.
    Neriishi K, Nakashima E, Akahoshi M, Hida A, Grant EJ, Masunari N, Funamoto S, Minamoto A, Fujiwara S, Shore RE.
    Radiology; 2012 Oct 01; 265(1):167-74. PubMed ID: 22875798
    [Abstract] [Full Text] [Related]

  • 30. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
    Grant EJ, Furukawa K, Sakata R, Sugiyama H, Sadakane A, Takahashi I, Utada M, Shimizu Y, Ozasa K.
    Lancet Oncol; 2015 Oct 01; 16(13):1316-23. PubMed ID: 26384241
    [Abstract] [Full Text] [Related]

  • 31. A pathology study of malignant and benign ovarian tumors among atomic-bomb survivors--case series report.
    Inai K, Shimizu Y, Kawai K, Tokunaga M, Soda M, Mabuchi K, Land CE, Tokuoka S.
    J Radiat Res; 2006 Mar 01; 47(1):49-59. PubMed ID: 16571918
    [Abstract] [Full Text] [Related]

  • 32. A long-term cohort study of the atomic-bomb survivors.
    Kodama K, Mabuchi K, Shigematsu I.
    J Epidemiol; 1996 Aug 01; 6(3 Suppl):S95-105. PubMed ID: 8800280
    [Abstract] [Full Text] [Related]

  • 33. Flexible dose-response models for Japanese atomic bomb survivor data: Bayesian estimation and prediction of cancer risk.
    Bennett J, Little MP, Richardson S.
    Radiat Environ Biophys; 2004 Dec 01; 43(4):233-45. PubMed ID: 15565453
    [Abstract] [Full Text] [Related]

  • 34. Corrections in the atomic bomb data to examine low dose risk.
    Baker GS, Hoel DG.
    Health Phys; 2003 Dec 01; 85(6):709-20. PubMed ID: 14626322
    [Abstract] [Full Text] [Related]

  • 35. Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.
    Schneider U, Walsh L.
    Radiat Environ Biophys; 2008 Apr 01; 47(2):253-63. PubMed ID: 18157543
    [Abstract] [Full Text] [Related]

  • 36. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
    Little MP.
    Int J Radiat Biol; 2002 Nov 01; 78(11):1001-10. PubMed ID: 12456287
    [Abstract] [Full Text] [Related]

  • 37. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K.
    Prev Med; 1997 Nov 01; 26(1):144-53. PubMed ID: 9010910
    [Abstract] [Full Text] [Related]

  • 38. Selection of reference groups in the Life Span Study of atomic bomb survivors.
    French B, Cologne J, Sakata R, Utada M, Preston DL.
    Eur J Epidemiol; 2017 Dec 01; 32(12):1055-1063. PubMed ID: 29204903
    [Abstract] [Full Text] [Related]

  • 39. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.
    Charles MW.
    J Radiol Prot; 2003 Dec 01; 23(4):457-9. PubMed ID: 14750694
    [No Abstract] [Full Text] [Related]

  • 40. Radiation dose response estimation with emphasis on low dose range using restricted cubic splines: application to all solid cancer mortality data, 1950-2003, in atomic bomb survivors.
    Nakashima E.
    Health Phys; 2015 Jul 01; 109(1):15-24. PubMed ID: 26011495
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.